Daré Bioscience, Inc.DARENASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P10
Near historical low
vs 5Y Ago
-4.4x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -51.48% |
| Q2 2025 | -37.81% |
| Q1 2025 | -30.62% |
| Q4 2024 | 24.63% |
| Q3 2024 | -46.15% |
| Q2 2024 | 47.12% |
| Q1 2024 | -11.74% |
| Q4 2023 | -43.08% |
| Q3 2023 | 10.44% |
| Q2 2023 | 20.39% |
| Q1 2023 | -61.31% |
| Q4 2022 | 190.81% |
| Q3 2022 | -34.36% |
| Q2 2022 | 17.09% |
| Q1 2022 | -18.42% |
| Q4 2021 | -31.79% |
| Q3 2021 | 42.13% |
| Q2 2021 | 28.14% |
| Q1 2021 | -13.71% |
| Q4 2020 | 7.01% |
| Q3 2020 | 11.83% |
| Q2 2020 | 133.11% |
| Q1 2020 | 0.25% |
| Q4 2019 | 20.75% |
| Q3 2019 | -21.77% |
| Q2 2019 | 48.43% |
| Q1 2019 | 1.80% |
| Q4 2018 | 14.93% |
| Q3 2018 | -34.76% |
| Q2 2018 | 104.05% |
| Q1 2018 | 61.62% |
| Q4 2017 | 139.53% |
| Q3 2017 | -78.27% |
| Q2 2017 | -72.22% |
| Q1 2017 | 46.07% |
| Q4 2016 | -55.09% |
| Q3 2016 | -5.76% |
| Q2 2016 | -23.01% |
| Q1 2016 | 36.51% |
| Q4 2015 | 0.92% |